Article Text

Download PDFPDF
Otago Glaucoma Surgery Outcome Study: long term results of cataract extraction combined with Molteno implant insertion or trabeculectomy in primary glaucoma
  1. A C B Molteno1,
  2. K W Whittaker1,
  3. T H Bevin1,
  4. P Herbison2
  1. 1Section of Ophthalmology, Department of Medical and Surgical Sciences, University of Otago Medical School, Dunedin, New Zealand
  2. 2Department of Preventive and Social Medicine, University of Otago Medical School, Dunedin, New Zealand
  1. Correspondence to: Professor A C B Molteno Section of Ophthalmology, Department of Medical and Surgical Sciences, University of Otago Medical School, P O Box 913, Dunedin, New Zealand; georgi.bondhealthotago.co.nz

Abstract

Background/Aims: To describe the long term results of cases of cataract extraction combined with either Molteno implant insertion or trabeculectomy for primary open angle glaucoma.

Methods: This prospective case series followed cases which had cataract extraction and Molteno implant insertion (45 eyes) or trabeculectomy (94 eyes) followed up for a mean of 5.3 years and 3.9 years respectively.

Results: Cataract extraction and Molteno implant insertion or trabeculectomy controlled the intraocular pressure at 21 mmHg or less with a probability of 1.00 (95% CI 0.93 to 1.00) at 10 years or more after operation and 0.94 (95% CI 0.89 to 0.99) and 0.73 (95% CI 0.46 to 0.99) at five and 10 years after operation respectively.

Conclusions: Cataract extraction combined with insertion of Molteno implants or trabeculectomy controlled the intraocular pressure in 100% (45/45) and 94% (88/94) of cases respectively.

  • glaucoma
  • cataract
  • combined operation
  • trabeculectomy
  • Molteno implant

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Proprietory interest: ACB Molteno declares a financial interest in Molteno implants. None of the other authors has any competing interests.